CVS - Earnings announcements

WOONSOCKET, R.I., April 6, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, May 6th, 2026, at 8:00 a.m. ET to discuss first quarter 2026 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year.About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of December 31, 2025, the

Fourth Quarter Highlights Total revenues increased to $105.7 billion, up 8.2% compared to prior yearGAAP diluted EPS of $2.30 and Adjusted EPS of $1.09Full-Year Highlights Total revenues increased to a record high $402.1 billion, up 7.8% compared to prior yearGAAP diluted EPS of $1.39 and Adjusted EPS of $6.75Generated cash flow from operations of $10.6 billionOperational Highlights CVS Pharmacy® successfully completed the transition to cost-based reimbursement across its Commercial, Third-Party Discount, Medicare and Medicaid businesses.Aetna® continues to improve the experience for health care professionals and their patients, approving more than 95% of all eligible prior authorizations wi

WOONSOCKET, R.I., Jan. 15, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Tuesday, February 10th, 2026, at 8:00 a.m. ET to discuss fourth quarter and full year 2025 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of S

WOONSOCKET, R.I., Jan. 9, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, February 11th, 2026, at 8:00 a.m. ET to discuss fourth quarter and full year 2025 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of

Financial Highlights Third quarter total revenues increased to a record high $102.9 billion, up 7.8% compared to prior yearThird quarter GAAP diluted loss per share of $3.13, inclusive of a $5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unitThird quarter Adjusted EPS of $1.60Generated year-to-date cash flow from operations of $7.2 billionOperational Highlights Aetna® receives industry-leading Medicare Advantage Star Ratings resultsLaunch of annual vaccination campaign at CVS Pharmacy® and MinuteClinic® locations nationwideCaremark® closes out another strong selling season with contract wins totaling nearly $6.0 billion and retention in the high nineties

WOONSOCKET, R.I., Sept. 30, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, October 29th, 2025, at 8:00 a.m. ET to discuss third quarter 2025 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of June 30, 2025,

Financial Highlights Second quarter total revenues increased to $98.9 billion, up 8.4% compared to prior yearSecond quarter GAAP diluted EPS of $0.80 and Adjusted EPS of $1.81Generated year-to-date cash flow from operations of $6.5 billionOperational Highlights Aetna® delivers distinctive advances in care navigationCVS Pharmacy® agreed to acquire certain prescription files and store locations from Rite AidCVS Caremark® demonstrates market-leading innovation in strong renewal and sales season2025 Full-Year Guidance Revised GAAP diluted EPS guidance range to $3.84 to $3.94 from $4.23 to $4.43Raised Adjusted EPS guidance range to $6.30 to $6.40 from $6.00 to $6.20Raised cash flow from operation

WOONSOCKET, R.I., June 30, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Thursday, July 31st, 2025, at 8:00 a.m. ET to discuss second quarter 2025 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of March 31, 2025, th

First Quarter Financial Highlights Total revenues increased to $94.6 billion, up 7.0% compared to prior yearGAAP diluted EPS of $1.41 and Adjusted EPS of $2.25Generated cash flow from operations of $4.6 billionOperational Highlights CVS Health to exit the individual exchange businessAetna® introduces new solutions to ease the patient and provider experienceCVS Caremark® makes formulary update to improve access to GLP-1 drugs2025 Full-Year Guidance Revised GAAP diluted EPS guidance range to $4.23 to $4.43 from $4.58 to $4.83Raised Adjusted EPS guidance range to $6.00 to $6.20 from $5.75 to $6.00Raised cash flow from operations guidance to approximately $7.0 billion from approximately $6.5 bil

WOONSOCKET, R.I., April 3, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Thursday, May 1st, 2025, at 8:00 a.m. ET to discuss first quarter 2025 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of December 31, 2024, th

Fourth Quarter Highlights Total revenues increased to $97.7 billion, up 4.2% compared to prior yearGAAP diluted EPS of $1.30 and Adjusted EPS of $1.19Full-Year Highlights Total revenues increased to $372.8 billion, up 4.2% compared to prior yearGAAP diluted EPS of $3.66 and Adjusted EPS of $5.42Generated cash flow from operations of $9.1 billion2025 Full-Year Guidance GAAP diluted EPS guidance range of $4.58 to $4.83Adjusted EPS guidance range of $5.75 to $6.00Cash flow from operations guidance of approximately $6.5 billionCEO Commentary"Our integrated model allows us to uniquely deliver a simpler, connected experience that saves time, saves money, and improves health. We have continued to s

WOONSOCKET, R.I., Jan. 13, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, February 12th, 2025, at 8:00 a.m. ET to discuss fourth quarter and full year 2024 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS Health CVS Health® is the leading health solutions company, broadening access to care for millions of people nationwide. We improve the health of communities across America through our local presence, digital channels and with over 300,000 dedica

Financial Highlights Third quarter total revenues increased to $95.4 billion, up 6.3% compared to the prior yearThird quarter GAAP diluted EPS of $0.07 and Adjusted EPS of $1.09Third quarter GAAP diluted EPS and Adjusted EPS include charges to record premium deficiency reserves of approximately $1.1 billion ($0.63 per share) in the Health Care Benefits segmentGenerated year-to-date cash flow from operations of $7.2 billionCEO Commentary "Our integrated model accelerates our ability to uniquely do what is most important to today's health care consumers: deliver lower cost of care, a simpler experience and better outcomes. Our third quarter results reflect strong performance in the Health Serv

WOONSOCKET, R.I., Oct. 7, 2024 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, November 6th, 2024, at 8:00 a.m. ET to discuss third quarter 2024 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues — includi

Financial Highlights Second quarter total revenues increased to $91.2 billion, up 2.6% compared to the prior yearSecond quarter GAAP diluted EPS of $1.41 and Adjusted EPS of $1.83Generated year-to-date cash flow from operations of $8.0 billion2024 Full-Year Guidance Revised GAAP diluted EPS guidance to a range of $4.95 to $5.20 from at least $5.64Revised Adjusted EPS guidance to a range of $6.40 to $6.65 from at least $7.00Revised cash flow from operations guidance to approximately $9.0 billion from at least $10.5 billionCEO Commentary"We have many points of differentiation that position us to win now and into the future. Our innovation is accelerating more transparent pharmacy reimbursement

WOONSOCKET, R.I., July 8, 2024 /PRNewswire/ -- CVS Health (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, August 7th, 2024, at 8:00 a.m. ET to discuss second quarter 2024 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues — including

First Quarter Highlights Total revenues increased to $88.4 billion, up 3.7% compared to prior yearGAAP diluted EPS of $0.88 and Adjusted EPS of $1.31Generated cash flow from operations of $4.9 billion2024 Full-Year Guidance Revised GAAP diluted EPS guidance to at least $5.64 from at least $7.06Revised Adjusted EPS guidance to at least $7.00 from at least $8.30Revised cash flow from operations guidance to at least $10.5 billion from at least $12.0 billionCEO Commentary"The current environment does not diminish our opportunities, enthusiasm, or the long-term earnings power of our company. We are confident we have a pathway to address our near-term Medicare Advantage challenges. We remain commi

WOONSOCKET, R.I., April 1, 2024 /PRNewswire/ -- CVS Health (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, May 1st, 2024, at 8:00 a.m. ET to discuss first quarter 2024 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues — including mo

WOONSOCKET, R.I., Feb. 7, 2024 /PRNewswire/ -- CVS Health Corporation (NYSE:CVS) today announced operating results for the three months and year ended December 31, 2023. FOURTH QUARTER HIGHLIGHTS  Total revenues increased to $93.8 billion, up 11.9% compared to prior yearGAAP diluted EPS of $1.58 and Adjusted EPS of $2.12KEY FINANCIAL DATA Three Months Ended December 31, In millions, except per share amounts 2023 2022 Change Total revenues  $   93,813 $   83,846 $     9,967 Operating income 3,373 3,659 (286) Adjusted operating income (1) 4,227 4,079 148 Diluted earnings per share $       1.58 $       1.77 $     (0.19) Adjusted EPS (2) $       2.12 $       2.04 $       0.08 FULL-YEAR HIGHLIG

WOONSOCKET, R.I., Jan. 12, 2024 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, February 7, 2024, at 8:00 a.m. ET to discuss fourth quarter and full year 2023 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health® is the leading health solutions company, broadening access to care for millions of people nationwide. We improve the health of communities across America through our local presence, digital channels and with over 300,000 dedicated

WOONSOCKET, R.I., Oct. 3, 2023 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, November 1, 2023, at 8:00 a.m. ET to discuss third quarter 2023 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS Health CVS Health® is the leading health solutions company, broadening access to care for millions of people nationwide. We improve the health of communities across America through our local presence, digital channels and with over 300,000 dedicated colleagues – in

WOONSOCKET, R.I., Aug. 2, 2023 /PRNewswire/ -- CVS Health Corporation® (NYSE:CVS) today announced operating results for the three months ended June 30, 2023. Second quarter highlights Total revenues increased to $88.9 billion, up 10.3% compared to prior yearGAAP diluted EPS of $1.48 and Adjusted EPS of $2.21Key financial data Three Months Ended June 30, In millions, except per share amounts 2023 2022 Change Total revenues  $   88,921 $   80,636 $     8,285 Operating income 3,234 4,669 (1,435) Adjusted operating income (1) 4,481 5,002 (521) Diluted earnings per share $       1.48 $       2.29 $     (0.81) Adjusted EPS (2) $       2.21 $       2.53 $     (0.32) Year-to-date highlights Total r

WOONSOCKET, R.I., July 6, 2023 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, August 2, 2023, at 8:00 a.m. ET to discuss second quarter 2023 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues – including

WOONSOCKET, R.I., May 3, 2023 /PRNewswire/ -- CVS Health Corporation (NYSE:CVS) today announced operating results for the three months ended March 31, 2023. FIRST QUARTER HIGHLIGHTS Total revenues increased to $85.3 billion, up 11.0% compared to prior yearGAAP diluted EPS of $1.65 and Adjusted EPS of $2.20Generated cash flow from operations of $7.4 billionKEY FINANCIAL DATA Three Months Ended March 31, In millions, except per share amounts 2023 2022 Change Total revenues  $   85,278 $   76,826 $     8,452 Operating income 3,446 3,545 (99) Adjusted operating income (1) 4,370 4,607 (237) Diluted earnings per share $       1.65 $       1.77 $     (0.12) Adjusted EPS (2) $       2.20 $       2.

WOONSOCKET, R.I., May 2, 2023 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced it has completed its acquisition of Oak Street Health. The acquisition will broaden CVS Health's value-based primary care platform and significantly benefit patients' long-term health by improving outcomes and reducing costs – particularly for those in underserved communities. On February 8, 2023, CVS Health announced it entered into a definitive agreement to acquire Oak Street Health in an all-cash transaction for $39 per share, representing an enterprise value of approximately $10.6 billion.

WOONSOCKET, R.I., April 4, 2023 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, May 3, 2023, at 8:00 a.m. ET to discuss first quarter 2023 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues – including mor

WOONSOCKET, R.I., Feb. 8, 2023 /PRNewswire/ -- CVS Health Corporation (NYSE:CVS) today announced operating results for the three months and year ended December 31, 2022. FOURTH QUARTER HIGHLIGHTS Total revenues increased to $83.8 billion, up 9.5% compared to prior yearGAAP diluted EPS of $1.75 and Adjusted EPS of $1.99KEY FINANCIAL DATA Three Months Ended December 31, In millions, except per share amounts 2022 2021 Change Total revenues  $   83,846 $   76,604 $     7,242 Operating income 3,618 2,229 1,389 Adjusted operating income (1) 4,006 4,147 (141) Diluted earnings per share $       1.75 $       0.98 $       0.77 Adjusted EPS (2) $       1.99 $       1.98 $       0.01 FULL-YEAR HIGHLIG

WOONSOCKET, R.I., Jan. 13, 2023 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, February 8, 2023, at 8:00 a.m. ET to discuss fourth quarter and full-year 2022 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated collea

WOONSOCKET, R.I., Nov. 2, 2022 /PRNewswire/ -- CVS Health Corporation (NYSE:CVS) today announced operating results for the three months ended September 30, 2022. THIRD QUARTER RESULTS Total revenues increased to $81.2 billion, up 10.0% compared to prior yearGAAP loss per share of $(2.60), inclusive of $5.2 billion pre-tax opioid litigation charges and a $2.5 billion pre-tax loss on assets held for sale related to the Omnicare® long-term care business ("LTC business")Adjusted EPS of $2.09KEY FINANCIAL DATA Three Months Ended September 30, In millions, except per share amounts 2022 2021 Change Total revenues  $   81,159 $   73,794 $     7,365 Operating income (loss) (3,931) 3,061 (6,992) Adjus

WOONSOCKET, R.I., Nov. 2, 2022 /PRNewswire/ -- CVS Health® (NYSE:CVS) announced today that it has agreed in principle to a financial resolution designed to substantially resolve all opioid lawsuits and claims against the company by states, political subdivisions, such as counties and cities, and tribes in the United States. If all conditions are satisfied and the non-monetary terms – which still need to be determined – are finalized, CVS Health has agreed it will pay approximately $5 billion ($4.9 billion to states and political subdivisions and approximately $130 million to t

WOONSOCKET, R.I., Oct. 6, 2022 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, November 2, 2022, at 8:00 a.m. ET to discuss third quarter 2022 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues – including

Advances long-term strategy by providing platform for growth in value-based care WOONSOCKET, R.I., DALLAS and NEW YORK, Sept. 5, 2022 /PRNewswire/ -- CVS Health® (NYSE:CVS) and Signify Health (NYSE:SGFY) ("Signify") have entered into a definitive agreement under which CVS Health will acquire Signify Health for $30.50 per share in cash, representing a total transaction value of approximately $8 billion. Signify Health is a leader in Health Risk Assessments, value-based care and provider enablement. With a network of more than 10,000 clinicians across all 50 states and a nationw

WOONSOCKET, R.I., Aug. 3, 2022 /PRNewswire/ -- CVS Health Corporation (NYSE:CVS) today announced operating results for the three months ended June 30, 2022. SECOND QUARTER HIGHLIGHTS Total revenues increased to $80.6 billion, up 11.0% compared to prior yearGAAP diluted EPS of $2.23 and Adjusted EPS of  $2.40KEY FINANCIAL DATA Three Months Ended June 30, In millions, except per share amounts 2022 2021 Change Total revenues  $   80,636 $   72,616 $     8,020 Operating income 4,569 4,326 243 Adjusted operating income (1) 4,810 4,887 (77) Diluted earnings per share $       2.23 $       2.10 $       0.13 Adjusted EPS (2) $       2.40 $       2.42 $      (0.02) YEAR-TO-DATE HIGHLIGHTS Total reve

WOONSOCKET, R.I., July 13, 2022 /PRNewswire/ -- CVS Health (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, August 3, 2022, at 8:00 a.m. ET to discuss second quarter 2022 financial results. An audio webcast of the conference call will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues –

WOONSOCKET, R.I., May 4, 2022 /PRNewswire/ -- CVS Health Corporation (NYSE:CVS) today announced operating results for the three months ended March 31, 2022. FIRST QUARTER HIGHLIGHTS Total revenues increased to $76.8 billion, up 11.2% compared to prior yearGAAP diluted EPS of $1.74 and Adjusted EPS of $2.22Generated cash flow from operations of $3.6 billionKEY FINANCIAL DATA Three Months Ended March 31, In millions, except per share amounts 2022 2021 Change Total revenues  $   76,826 $   69,097 $     7,729 Operating income 3,490 3,577 (87) Adjusted operating income (1) 4,483 4,205 278 Diluted earnings per share $      1.74 $      1.68 $      0.06 Adjusted EPS (2) $      2.22 $      2.04 $  

WOONSOCKET, R.I., April 4, 2022 /PRNewswire/ -- CVS Health (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, May 4, 2022, at 8:00 a.m. ET to discuss first quarter 2022 financial results. An audio webcast of the conference call will be broadcast simultaneously through the Investor Relations portion of the CVS Health website for all interested parties. To access the website, visit http://investors.cvshealth.com. The webcast will be archived and available on the website for one year following the conference call. About CVS HealthCVS Health is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of

WOONSOCKET, R.I., Feb. 9, 2022 /PRNewswire/ -- CVS Health Corporation (NYSE:CVS) today announced operating results for the three months and year ended December 31, 2021. FOURTH QUARTER HIGHLIGHTS KEY FINANCIAL DATA Total revenues increased to $76.6 billion, up 10.1% compared to prior year GAAP diluted EPS from continuing operations of $0.98 and Adjusted EPS of $1.98FULL-YEAR HIGHLIGHTS Total revenues increased to $292.1 billion, up 8.7% compared to prior year GAAP diluted EPS from continuing operations of $5.95 and Adjusted EPS of $8.40 Generated cash flow from operations of $18.3 billion Net repayments of long-term debt of $8.8 billionKEY FINANCIAL DATA Three Months Ended December 31, In m

WOONSOCKET, R.I., Jan. 6, 2022 /PRNewswire/ -- CVS Health (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, February 9, 2022, at 8:00 a.m. ET to discuss fourth quarter and full year 2021 financial results. An audio webcast of the conference call will be broadcast simultaneously through the Investor Relations portion of the CVS Health website for all interested parties. To access the webcast, visit http://investors.cvshealth.com. The webcast will be archived and available on the website for one year following the conference call. About CVS HealthCVS Health is the leading health solutions company, delivering care like no one else can. We reach more people and imp

WOONSOCKET, R.I., Nov. 3, 2021 /PRNewswire/ -- CVS Health Corporation (NYSE:CVS) today announced operating results for the three months ended September 30, 2021. KEY FINANCIAL DATA   Three Months Ended September 30, In millions, except per share amounts 2021 2020 Change Total revenues  $ 73,794 $ 67,056 $ 6,738 Operating income 3,061 3,249 (188) Adjusted operating income (1) 4,073 3,622 451 Diluted earnings per share $ 1.20 $ 0.93 $ 0.27 Adjusted EPS (2) $ 1.97 $ 1.66 $ 0.31 CEO COMMENTARY "We outperformed expectations once again and continue to lead the way in changing how, when and where care is delivered for millions of Americans," said CVS Health President and CEO Karen S. Lynch. "Our s

WOONSOCKET, R.I., Oct. 1, 2021 /PRNewswire/ -- CVS Health Corporation ("CVS Health") (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, November 3, 2021, at 8:00 a.m. (ET) to discuss its financial results for the third quarter of 2021. An audio webcast of the conference call will be broadcast simultaneously through the Investor Relations portion of the CVS Health website for all interested parties. To access the webcast, visit http://investors.cvshealth.com. This webcast will be archived and available on the website for a one-year period following the conference call. About CVS HealthCVS Health is the leading health solutions company, delivering care in ways no

WOONSOCKET, Rhode Island, Aug. 4, 2021 /PRNewswire/ -- CVS Health Corporation (NYSE:CVS) today announced operating results for the three months ended June 30, 2021. Second Quarter Highlights: Total revenues increased to $72.6 billion, up 11.1% compared to prior year GAAP diluted EPS of $2.10 and Adjusted EPS of $2.42Year-to-date Highlights: Total revenues increased to $141.7 billion, up 7.3% compared to prior year GAAP diluted EPS of $3.78 and Adjusted EPS of $4.46 Generated cash flow from operations of $8.7 billion Repaid $5.4 billion of long-term debt2021 Full Year Guidance: Raised GAAP diluted EPS guidance range to $6.35 to $6.45 from $6.24 to $6.36 Raised Adjusted EPS guidance range to

WOONSOCKET, R.I., July 21, 2021 /PRNewswire/ -- CVS Health Corporation ("CVS Health") (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, August 4, 2021, at 8:00 a.m. (ET) to discuss its financial results for the second quarter of 2021. An audio webcast of the conference call will be broadcast simultaneously through the Investor Relations portion of the CVS Health website for all interested parties. To access the webcast, visit http://investors.cvshealth.com. This webcast will be archived and available on the website for a one-year period following the conference call. About CVS HealthWe are a diversified health services company with more than 300,000 employees u